Member Info for Gizzard

FinnCap
Synairgen (SNG) : Corp
£14m placing to fund COVID-19 activities
Key data

Share price (p) 46.5
Target price (p) 120.0
Market cap (£m) 69.5
Enterprise value (£m) 67.0
Synairgen has raised £14.0m to fund a Phase II trial for SNG001 in COVID-19 disease, which is due to commence enrolment imminently after gaining rapid permissions for the UK’s MHRA and HRA. This is a significant breakthrough for the company and the global fight against COVID-19, having achieved these permissions ahead of the expected rapid increase in number of hospitalised COVID-19 patients. A successful outcome from the pilot phase will have substantial commercial value. The risk/reward profile, given earlier evidence that SNG001 has a beneficial in vitro effect in MERS and SARS coronaviruses and has been shown to be safe and well tolerated in asthma/COPD patients, is skewed significantly to the upside, particularly given the potential for first revenues in 2020. Not only would a positive trial help to address the current COVID-19 crisis but it could enable governments to stockpile a broad-spectrum antiviral product for future pandemics. We introduce a 120p target with potential further upside. Buy

The MMs are collecting stock, plain to see, can't wait for the results to start to come back.

We all know it's the best test around for speed and accuracy some people just don't want to here the truth...

Dream on wish you luck with that prediction.

(Mohh) Because he likes to spread fear in order to buy on the cheap.

Opportunity here not to pass up...MMs playing a blinder yet again.

Buying at 58.35 nice opportunity over 10% swing from todays high.

MMs work together to lock people out criminal.

I'm amazed that this hasn't flown...

What’s exciting us is the agreement for contract manufacturing services for ‘part’ of a COVID-19 Test. The agreement is with a subsidiary of Novacyt (LON:NCYT) which recently recorded a £131m Mkt Cap as the shares doubled on announcements it’s diagnostic tests kits went into production.
Initially, Ygen are contracted to produce critical components but the agreement could soon be expanded.

That's compelling article and a reason to buy imo.. great find

'Trading Strategy
At a near £100m market cap a moderate upgrade seems anticipated, the risk from here however seems to be missing the Covid -19 assisted upside.'

Buy

Only going one way and that's up, forget the DM hack's stupid article we need tests by the millions it's as simple as that.GLA

Yes he was sounding like a politician - not answering the direct question. Maybe told not to.

More fool them, I agree this will continue its rise GLA

Mentioned around 12 mins 10 seconds trials started last week sounds very encouraging.

People in at 4.50 will take their profits and leave an amount tro run free.

It’s the blame game the Daily Mail won’t attack the government so they blame the one company that could save millions of lives. Unlike Johnson and his health advisers who’ve played this so badly. Bunch of amateurs.

Poor journalism sends it down, typical Daily Mail hack with no knowledge.

Lots have been mugged, sheep follow sheep and they should follow the RNSs.

That's the point know one knows, but what we do know is that sales are continuing constantly so on that proviso it's a buy as revenue is growing daily.

UK